Pulmonary – FM EORE (2025) | 20 High-Yield Q&As | Asthma, COPD, TB, Pneumonia

This document provides a focused collection of 20 high-yield, exam-relevant question-and-answer sets for the Pulmonary section of the Family Medicine End of Rotation Exam (FM EORE) for 2025. Covering essential respiratory conditions, it addresses the pathophysiology, clinical presentation, diagnostics, and treatments for asthma, COPD (chronic bronchitis and emphysema), pneumonia (including bacterial and pneumocystis), tuberculosis, lung cancer types (SCLC and NSCLC), and obstructive sleep apnea. Each condition is linked with relevant pharmacologic therapies, diagnostic criteria (e.g., CURB-65, spirometry findings, CXR patterns), and microbial etiologies where applicable. Treatment guidelines are outlined using first-line therapies and clinical indicators, including use of SABAs, LABAs, corticosteroids, macrolides, fluoroquinolones, anti-TB drugs, and more. Mechanisms of action for drug classes are clearly defined, offering insight into clinical decision-making. This content is specifically designed for medical students preparing for their Family Medicine shelf exams, USMLE Step 2 CK, and clinical rotations, and is also relevant for physician assistant, nurse practitioner students, and international medical graduates. Keywords: pulmonary, FM EORE, USMLE Step 2, asthma, COPD, pneumonia, tuberculosis, pneumocystis jirovecii, lung cancer, respiratory pharmacology, obstructive sleep apnea, macrolides, corticosteroids, spirometry, CURB-65, medical student pulmonary